Dheeraj Shaha

Key Factors Driving Market Growth: The growth of protein expression market is driven majorly by the increasing incidence of chronic diseases, growth in the geriatric population, and increasing demand for protein biologics. Emerging economies are likely to create significant growth opportunities for players in the market. Revenue Growth Analysis: [173 Pages Report] The global protein expression market size is projected to reach USD 4.1 billion by 2025 from USD 2.2 billion in 2020, at a CAGR of 13.2% The study involved four major activities in estimating the current size for protein expression market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter market breakdown and data triangulation was used to estimate the market size of segments and subsegments. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=180323924 Therapeutic applications held the largest share of the protein expression market Based on the applications, the protein expression industry is segmented into therapeutic, industrial, and research. Therapeutic applications accounted for the largest share of this market in 2019. The growth of this segment is attributed to the rising incidences of the disease and growing R&D activity. The large share of this segment can be attributed to an increase in proteomics-based research and the rising prevalence of chronic diseases across the globe. The reagents segment accounted for the largest share of the protein expression industry in 2019. Based on product and service, the protein expression industry is segmented into reagents, expression vectors, competent cells, instruments, and services. The reagents segment accounted for the largest share of the market in 2019. The large share of this segment is mainly due to the increasing research activities in the field of protein expression and the large-scale production of antibodies and vaccines. The Asia Pacific protein expression market is expected to grow at the highest CAGR Asia Pacific is expected to grow at the highest rate in the market. The major factors driving the growth of this market include high incidence of chronic diseases, increasing public and private investments, and increase in life sciences research. Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=180323924 North America dominated the protein expression sector, followed by Europe. The major factors driving the growth of this market include the increasing incidence of chronic diseases, growth in the geriatric population, and increasing demand for protein biologics. Key Players: The prominent players in the global protein expression market include Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), Genscript Biotech Corporation (US), Takara Bio, Inc. (Japan), Bio-Rad Laboratories (US), Lonza (US), Promega Corporation (US), New England Biolabs (US), Oxford Expression Technologies Ltd. (US), and Synthetic Genomics Inc. (US). Thermo Fisher Scientific Inc. is the largest player in the protein expression market. The large share of this company can be attributed to its strong suite of expression vectors, reagents, competent cells, and instruments. Owing to its strong sales and distribution network, the company has a significant global footprint. Additionally, the large number of production sites give it a competitive advantage over other players in the market. The company focuses on product launches to create a strong foothold in the market. In 2018, Thermo Fisher Scientific Inc. launched the Gibco ExpiSf System, the first-ever chemically defined protein expression system. The company further intends to strengthen its presence in this market by investing in R&D. Its extensive R&D activities enable it to increase its depth of capabilities in protein expression solutions and services and to provide innovative products and services in the protein expression market space.

Key Factors Driving Market Growth: The Increasing spending on pharmaceutical R&D, growing food safety concerns, standardization of workflows, stringent regulatory control in the healthcare industry are fuelling the growth of the lab automation market. Moreover, high demand in the emerging nation and the growth of the pharmaceutical and biotechnology industries are some of the other major factors driving the growth of this market. Expected Revenue Growth: The lab automation market size will grow to USD 5.5 billion by 2025 from USD 4.3 billion in 2020, at a CAGR of 5.2% during the forecast period. This report aims to provide detailed insights into the global market. It provides valuable information on the type, procedure, application, and region in the market. Furthermore, the information for these segments, by region, is also presented in this report. Leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1158 The Automated Workstations segment is expected to dominate the lab automation market, by product type, during the forecast period. Automated workstations are compact & standalone, capable of conducting a particular task unattended. Owing to the easy integration with both existing and upcoming systems are favorable options for customers looking to introduce automation in their labs. The Automated workstations is further segmented to automated liquid handling systems, microplate reader, automated Elisa system, automated nucleic acid purification systems. The automated liquid handling system are growing at the highest CAGR. Owing to an increase in the number of tests carried out in pharmaceutical labs for screening compounds, optimizing leads, determining drug properties with absorption, distribution, metabolism, and excretion (ADME), and toxicity has favored the argument for automation. The drug discovery is expected to be the fastest-growing lab automation market, by application, during the forecast period. The drug discovery, by application, laboratory automation market is estimated to grow at the fastest rate during the forecast period. This is mainly because of the increasing industry-academia collaboration for the development and use of fully automated, ultrahigh-throughput systems. Moreover, investments in automation permit the safer generation of data with improved accuracy, precision, reproducibility, and traceability, allowing drug discovery scientists to utilize higher–quality data in the hypothesis–driven research required to discover new medicines. Thus, growing the market of drug discovery segment. Request For Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=1158 North America likely to emerge as the largest lab automation market In this report, the laboratory automation market has been analyzed for four regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Growth in the North American market is also supported by the demand for the integration of laboratory systems, rising government funding for research, growth in biobanks, need for early drug discovery, and stringent regulatory requirements. Thus, North America dominated the market during the forecasted period. To enable an in-depth understanding of the competitive landscape, the report includes the profiles of some of the top players in the market. Some of the key players are Thermo Fisher Scientific, Inc. (US), PerkinElmer Inc,(US) Agilent Technologies (US), Danaher Corporation (US), F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), and Tecan Group Ltd. (Switzerland).The leading players are adopting various strategies to increase their share in the lab automation market.

Major Behavioral Software Market Growth Drivers:  Increasing adoption of mental health software, availability of government funding, government initiatives to encourage EHR adoption in behavioral health organizations, favorable behavioral health reforms in the US, and high demand for mental health services amidst provider shortage are the major factors driving the growth of behavioral health software market. Expected Revenue Growth in Behavioral Software Market: [217 Pages Report] The behavioral health software market is expected to reach USD 4.9 billion by 2026 from USD 2.0 billion in 2021, at a CAGR of 19.6%  This report aims to provide detailed insights into the global behavioral health software market. It provides valuable information on the type, procedure, application, and region in the behavioral software market. Furthermore, the information for these segments, by region, is also presented in this report. Leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market.  Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=45953340  Driver: Increasing Adoption of BHS:  High healthcare costs for the treatment of behavioral health-related problems or mental illnesses form a key concern for governments. Globally, depression is a common mental disorder; more than 264 million people of all ages suffer from depression. The global cost for the treatment of mental illnesses was ~USD 2.5 trillion in 2020; this figure is projected to reach USD 6 trillion by 2030 (Source: Lancet Commission). Additionally, serious mental illnesses cost the US an estimated USD 193.2 billion in lost earnings per year (Source: National Alliance of Mental Illness). In Canada, mental health problems cost more than USD 42.4 billion (CAD 51 billion) every year (Source: Centre for Addiction and Mental Health).  The need for and generation of excessive paperwork (resulting in loss of productivity among clinicians) and improper revenue cycle management by behavioral health organizations are the major factors resulting in the high cost of treatments. The need to resolve these issues has boosted attention on and the adoption of behavioral health software as a means of reducing medication errors and paperwork, enhancing productivity by ensuring quick patient data access, improving workflow efficiency, and minimizing healthcare costs. These benefits of behavioral health software have driven their adoption, especially among large hospitals and community clinics.  Behavioral Software Market Opportunity: Emerging Markets  Emerging markets such as the Asia Pacific, Latin America, and the Middle East and Africa are expected to offer significant growth opportunities for players operating in the behavioral health software market, especially those that are unable to meet the standards set by the Federal Government in the US. Government initiatives to establish standards, regulations, and infrastructure will encourage healthcare providers to adopt EMR and EHR technology in Australia. The Australian government has been taking several initiatives to increase the adoption of IT in healthcare to reduce errors and increase efficiency.  On this front, in March 2013, the State of South Australia started developing the “careconnect.sa” program to fully integrate EHR systems statewide. The Government of Australia is also actively promoting the electronic exchange of health information as part of the National E-Health Strategy. In its 2015-16 Federal Budget, the government allocated USD 485.1 million to strengthen eHealth governance arrangements (Source: Australian Digital Health Agency). Such initiatives are responsible for increasing the implementation of EMRs and EHRs in Australia.  Request Sample Report of Behavioral Software Market: https://www.marketsandmarkets.com/requestsampleNew.asp?id=45953340   Key Players In Behavioral Health Software Market:  Major players operating in the behavioral health software market include Advanced Data Systems (US), AdvancedMD (US), Cerner (US), Compulink (US), Core Solutions (US), Credible Behavioral Health (US), Kareo (US), Meditab Software (US), Mindlinc (US), Netsmart (US), Nextgen Healthcare (US, Qualifacts (US), The Echo Group (US), Valant (US), Welligent (US), Cure MD(US), Epic systems corporations (US), Accumedic (US), Mediware(US), Allscripts (US)

Key Factors Driving Pain Management Devices Market Growth:Pain management devices are used to manage chronic and acute pain in patients suffering from various types of disease conditions, such as cancer, neurological disorders, and musculoskeletal disorders, among others. These devices restore the ability to do everyday activities, decrease the need for oral pain medications, and improve the quality of life of patients suffering from these conditions.Revenue Growth Analysis:[249 Pages Report] The global pain management devices market is projected to reach USD 3.3 billion by 2026 from USD 2.2 billion in 2021, at a CAGR of 8.6%The study involved four major activities in estimating the current size of the Pain Management Devices Market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the size of the segments and subsegments.Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=91418163Driver: Growing Number of Surgical Procedures PerformedOver the years, there has been a significant rise in the number of surgical procedures performed across the globe. This can be attributed to the rising geriatric population and the growing prevalence of obesity and other lifestyle diseases. Obesity is one of the key causes of cardiovascular and orthopedic diseases. Analgesia/pain management is the key application area of infusion pumps. Infusion pumps are also widely used for the local administration of narcotic analgesics and anesthetics following bariatric surgery, cardiothoracic surgery, and laparoscopic cholecystectomy.Pain management devices are used to administer critical fluids, neurostimulations and ablation that involves including high-risk medications. Errors in using these systems can cause serious harm to patients and may even lead to death. According to the Institute of Medicine (US), approximately 1.5 million patients annually experience medication errors costing USD 8,750 per Potential Adverse Drug Event (PADE).High Growth Opportunities in Emerging Markets:Emerging economies such as China, India, and Brazil offer significant growth opportunities for players in the pain management devices market. This can primarily be attributed to the diversified healthcare markets in this region, the growing incidence of chronic disorders, and increasing R&D initiatives to develop innovative medical technologies. In addition, infrastructural developments in healthcare facilities, increasing healthcare expenditures, and the low-cost manufacturing advantage offered by emerging countries in the Asia Pacific are expected to encourage market players to invest in this region in the coming years.North America to Dominate the Pain Management Devices Market:North America dominated the pain management devices industry, with a share of 52.3% in 2020, followed by Europe and Asia Pacific. North America is expected to grow at a 7.3% CAGR during the forecast period. North America has been among the frontrunners in developing pain management devices services in the healthcare industry. The market in the US is expected to offer growth opportunities in the coming years owing to the increasing incorporation of pain management devices in the ambulatory care centers. Many major global players are also based in the US, owing to which the country has become a center of innovation in the market.Request Sample Report:https://www.marketsandmarkets.com/requestsampleNew.asp?id=91418163 Key Players:The key players in pain management devices market have a strong foothold in the market and offer a wide range of products. Medtronic PLC (Ireland), Boston Scientific (US), Abbott (US), Becton, Dickinson and Company (US), Baxter International (US), B. Braun Melsungen AG (Germany), Stryker (US), Smiths Medical (US), Moog Inc. (US), Avanos Medical, Inc. (US), Nipro Corporation (Japan), Atricure (US), Nevro Corp. (US), Micrel Medical Devices SA (Greece), InfuTronix Solutions LLC (US), Teleflex, Inc. (US), Mindray Medical International Limited (China), Shenzhen MedRena Biotech Co., Ltd. (China), Epic Medical (Singapore), Bioness (US), Microtransponder (US), Neuronano (Sweden), Gimer Medical (Taiwan), Bluewind Medical (Israel), Soterix Medical Inc. (US) and other players.Medtronic is the leading player in the pain management devices market. The company, as part of its marketing and sales strategy, focuses on rapid and cost-effective product delivery to its global customers. Additionally, the company maintains strong relationships with physicians and providers to gain a detailed understanding of their requirements. The company has gained a major share in the neuromodulation market because of its diversified product portfolio, widespread geographical presence, focus on inorganic growth strategies, strong focus on R&D, and aggressive marketing and sales strategies.